Bargains can still be found in this bull market.
The stocks below may be cheap, but they all offer impressive value for the money and big upside potential. Furthermore, all five of these cheap stocks to buy have significant support from Wall Street’s best-performing analysts. While it may be difficult to find compelling stocks for under $10, we’ve selected five gems worth exploring.
To pinpoint these top stocks, we turned to TipRanks’ stock screener. We used this screener, which covers over 5,000 stocks, to find only the best stocks with a ‘Strong Buy’ analyst consensus rating. This is based on all the ratings that a stock has received in the last three months.
Bellicum Pharmaceuticals (BLCM) Current share price: $8.98
Clinical-stage cancer immunotherapy company Bellicum Pharmaceuticals has just scored a big regulatory win. The U.S. Food and Drink Administration (FDA) announced that it is lifting a U.S. clinical hold on Bellicum’s lead product candidate BPX-501. On the news, the share price exploded over 40% to $8.98. But the best part is the massive potential growth ahead. Our data shows that the average analyst price target of $20.40 indicates 127% upside potential from current share levels.
Hot Performing Stocks For 2018: Yum! Brands, Inc.(YUM)
- [By ]
Nearly 10 months ago, Cramer told viewers to buy shares of Yum Brands (YUM) and sell its counterpart, Yum China (YUMC) . Since that recommendation, shares of Yum are up 11%, while Yum China has fallen over 5%. What should investors do now? Cramer took a fresh look to find out.
- [By Nicholas Rossolillo]
Pizza Hut, on the other hand, took a step back after rebounding at the end of 2017. Total sales dropped 1%, driven by a 5% decline in same-store sales and slightly offset by 109 more locations in operation than last year. Pizza Hut has had its struggles the last few years in China. Pizza doesn’t carry the same status as a dietary staple in the country as it does here in the U.S. Yum has been trying to change that by innovating the menu around local tastes, but it reports that the strategy will take some more time before its efforts can be judged. Yum China only gained independence from former parentYum! Brands(NYSE:YUM) at the end of 2016.
- [By Logan Wallace]
Public Employees Retirement Association of Colorado reduced its position in shares of Yum! Brands (NYSE:YUM) by 6.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 59,869 shares of the restaurant operator’s stock after selling 3,827 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Yum! Brands were worth $5,097,000 as of its most recent SEC filing.
- [By ]
Nearly 10 months ago, Cramer told viewers to buy shares of Yum Brands (YUM) and sell its counterpart, Yum China Holdings (YUMC) . Since that recommendation, shares of Yum are up 11%, while Yum China has fallen over 5%. What should investors do now? Cramer took a fresh look to find out.
- [By ]
These figures should be a relief for Niccol, who joined the company from Yum! Brands’ (YUM) Taco Bell in February. While he was largely welcomed by investors and received industry affirmation, some critics were skeptical of his franchising background, operational savvy and the disparity in ethos between Chipotle and Taco Bell.
- [By ]
However, Cramer did have some positive advice about dealing with China. “The one thing I tell people is that if you want surefire China trades: you go long Yum Brands (YUM) and short Yum China (YUMC) , as they have similar growth rates and similar price to earnings multiples, but only one can be brought low by the [People’s Republic of China].”
Hot Performing Stocks For 2018: Revlon, Inc.(REV)
- [By Lisa Levin] Companies Reporting Before The Bell
Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
Choice Hotels International, Inc. (NYSE: CH
Hot Performing Stocks For 2018: Armstrong World Industries Inc(AWI)
- [By Ethan Ryder]
AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.
Hot Performing Stocks For 2018: 1-800 FLOWERS.COM Inc.(FLWS)
- [By Max Byerly]
1-800-Flowers (NASDAQ:FLWS) had its price target hoisted by DA Davidson from $10.00 to $11.00 in a research report sent to investors on Wednesday. The brokerage currently has a neutral rating on the specialty retailer’s stock. DA Davidson also issued estimates for 1-800-Flowers’ FY2018 earnings at $0.42 EPS, Q1 2019 earnings at ($0.24) EPS, Q2 2019 earnings at $1.02 EPS, Q3 2019 earnings at ($0.16) EPS, Q4 2019 earnings at ($0.10) EPS and FY2019 earnings at $0.54 EPS.
Hot Performing Stocks For 2018: CSX Corporation(CSX)
- [By Dan Caplinger]
The railroad industry has gone through a lot in recent years, as turbulent conditions in many of the end markets that key railroad customers serve have led to volatile levels of volume and revenue. CSX (NASDAQ:CSX) has also had to deal with an unexpected CEO transition in the middle of turnaround efforts that the railroad company had hoped would be able to pull it out of a long funk.
- [By Asit Sharma]
It also hasn’t helped that competitorCSX Corporation (NASDAQ:CSX) just reported a massive year-over-year jump of nearly 6 percentage points in its operating ratio, from 69.4% to 63.7%, in the first quarter of 2018.I recently described how a more aggressive approach to operations appears to be fueling CSX’s productivity. And yet it should be acknowledged that CSX isn’t facing a congestion event like Union Pacific’s.
- [By Garrett Baldwin]
Market fears of an escalating Middle Eastern conflict abated thanks to last week’s military strikes against the Syrian government. On Friday, April 13, U.S. forces joined the United Kingdom and France in retaliation for a chemical gas attack carried out by the Syrian government. The military exercise came at a time that tensions are also rising in the Middle East between Saudi Arabia and Iran.
Today, several members of the U.S. Federal Reserve will be speaking at events around the globe, including San Francisco Fed President John Williams and Chicago Fed Bank President Charles Evans. But no one will be more watched today than Fed Gov. Randal Quarles, who will testify before the U.S. House Financial Services Commission. Quarles will provide testimony on the central bank’s plans to regulate and oversee the financial system. Expect a wealth of questions about the Fed’s plans to raise interest rates and manage its massive balance sheet. Money MorningLiquidity SpecialistLee Adler offers you advice on how to play the Fed’s problems, right here.
Four Stocks to Watch Today: GS, NFLX, TSLA, and ROKU
Shares of Goldman Sachs Group Inc. (NYSE: GS) added 0.6% after the Wall Street bank easily topped Q1 earnings and revenue estimates. The firm reportedearnings per share (EPS) of $6.95 on top of more than $10 billion in revenue. Analysts projected EPS of $5.67 on top of $8.89 billion. The investment bank hiked its quarterly dividend and said that revenue from equity trading rallied thanks to an uptick in recent market volatility.
Shares of Tesla Inc. (Nasdaq: TSLA) are flat on the news that the firm will suspend production of its Model 3 vehicles. The firm said the temporary halt in production will aim to “improve automation” and address ongoing bottlenecks in its production process.
Shares of Roku Inc. (Nasdaq: ROKU) popped more than 8.2% on news that Steven Cohen’s family office has taken a passive 5.1% stake in the company. The streaming device manufactur
Hot Performing Stocks For 2018: Prothena Corporation plc(PRTA)
- [By Chris Lange]
Prothena Corp. PLC (NASDAQ: PRTA) shares hit a multiyear low on Monday, one not seen since 2013. This came on the heels of news that the company would be discontinuing development of NEOD001, an investigational antibody that was being evaluated for the treatment of AL amyloidosis.
- [By Cory Renauer]
April’s been a month of biotech bloodbaths. In a 15-day span, Incyte Corporation (NASDAQ:INCY), Prothena Corporation PLC (NASDAQ:PRTA), and Celldex Therapeutics Inc. (NASDAQ:CLDX)have all reported clinical trial failures that have hammered theirstock prices.
- [By Lisa Levin]
Prothena Corporation plc (NASDAQ: PRTA) shares dropped 69 percent to $11.585 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction. Unfortunately, there were no statistically significant difference between the two treatment groups.
- [By Paul Ausick]
Prothena Corp. plc (NASDAQ: PRTA) traded down 70% Monday to post a new 52-week low of $11.05 after closing Friday at $36.84. The stock’s 52-week high is $70.00. Volume was more than 20 times the daily average of around 580,000 shares. The company is stopping development on an amyloidosis treatment following a failed late-stage trial.
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent